pCloud Lifetime
Tuesday, October 19, 2021

Imec signs licensing agreement with miDiagnostics to commercialize its patented technology for fast and reliable COVID-19 diagnosis based on exhaled breath

Printed: Oct. 14, 2021 at 10:39 AM CDT|Up to date: moments in the past

LEUVEN, Belgium, Oct. 14, 2021 /PRNewswire/ — Imec, the world’s main analysis and innovation hub in nanoelectronics and digital know-how, and miDiagnostics, a spin-off of imec in collaboration with Johns Hopkins College specialised within the growth of point-of-care exams for screening, diagnosing and monitoring a variety of well being situations, announce that they’ve signed a non-exclusive licensing settlement for imec’s patented know-how whereby aerosols and droplets from exhaled breath are captured for screening for viral RNA by way of miDiagnostics ultrafast PCR know-how. The settlement permits miDiagnostics to kickstart the commercialization of a COVID-19 breathalyzer (versus classical COVID-19 testing strategies primarily based on blood, saliva or a pattern from the nostril/throat cavity).

A demonstration sample of the proof-of-concept breath sampler, developed by imec.
An indication pattern of the proof-of-concept breath sampler, developed by imec.

Previously 12 months, imec developed a breath sampler primarily based on imec’s distinctive chip know-how, and carried out medical research with the college hospital and college of Leuven exhibiting that imec’s breath sampler is able to capturing the SARS-CoV-2 virus in exhaled air, and detecting the viral RNA rapidly and reliably. Additionally, imec developed a sampling instrument integrating the breath sampling know-how and imec’s ultra-fast PCR-test, and optimized the robustness and ease of use, to realize a functioning proof-of-concept thus far.

“I notice with nice satisfaction that now we have run a formidable course up to now months,” says Luc Van den hove, CEO at imec. “We’ve succeeded in remodeling a promising idea and groundbreaking know-how right into a practical proof-of-concept that has handed each consumer exams and medical research. That is the primary time that now we have gone this far within the growth of our chip know-how in the direction of commercialization. With this proof-of-concept, we are able to reveal a lot nearer to the market the added worth of our know-how, whereas considerably lowering the time-to-market for our companions. The license settlement with miDiagnostics is a crucial milestone for imec: Our breakthrough know-how will assist curb the COVID-19 pandemic within the foreseeable future.”

As COVID-19 will definitely not be the final virus to engulf the world, imec is already wanting additional, by investigating how its patented know-how may also be utilized to diagnose different infectious airborne ailments. As well as, imec can also be wanting into its software in diagnosing ailments akin to most cancers. corporations are welcome to affix this effort.

“Regardless of the vaccination campaigns, there’s nonetheless an ideal want for accessible and dependable speedy exams to curb new virus outbreaks or to keep away from pointless quarantine. With our license to imec’s groundbreaking know-how, we goal to make our ultra-fast PCR know-how, which we now use for nasal swabs, additionally suitable with exhaled air the proper pattern for silicon-based PCR. This primary prototype will likely be examined on the airport in November in collaboration with Brussels Airport, Ecolog and Eurofins,” says Katleen Verleysen, CEO of miDiagnostics.

“Our analysis investments by way of imec result in new technological breakthroughs. The interaction between information, analysis and entrepreneurship supplies financial and social added worth. With the brand new breathalyzer, we’re additionally making historical past in testing COVID-19. The event of those exams is of nice significance for public well being. On this approach we will handle this pandemic even higher and enhance the consolation for individuals who have to be examined. That’s the reason I’m proud that now we have been capable of help the event and analysis of imec,” says Flemish Minister of Innovation Hilde Crevits

About imec

Imec is a world-leading analysis and innovation heart in nanoelectronics and digital applied sciences. Imec leverages its state-of-the-art R&D infrastructure and its staff of greater than 5,000 workers and prime researchers, for R&D in superior semiconductor and system scaling, silicon photonics, synthetic intelligence, past 5G communications and sensing applied sciences, and in software domains akin to well being and life sciences, mobility, {industry} 4.0, agrofood, sensible cities, sustainable vitality, schooling… Imec unites world-industry leaders throughout the semiconductor worth chain, Flanders-based and worldwide tech, pharma, medical and ICT corporations, start-ups, and academia and information facilities. Imec is headquartered in Leuven (Belgium), and has analysis websites throughout Belgium, in the Netherlands, Taiwan and the USA, and workplaces in China, India and Japan. In 2020, imec’s income (P&L) totaled 680 million euro.

Additional info on imec could be discovered at www.imec-int.com.

Imec is a registered trademark for the actions of imec Worldwide (IMEC Worldwide, a authorized entity arrange beneath Belgian legislation as a “stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Authorities), imec the Netherlands (Stichting IMEC Nederland),  imec Taiwan (IMEC Taiwan Co.), imec China (IMEC Microelectronics (Shanghai) Co. Ltd.), imec India (IMEC India Non-public Restricted), imec San Francisco (IMEC Inc.) and imec Florida (IMEC USA Nanoelectronics Design Middle Inc.).

About miDiagnostics

miDiagnostics is utilizing silicon chip know-how which can convey miniaturized, speedy, easy-to-use, lab-quality exams direct to the affected person and clinician. Combining a nanofluidic processor on a chip and a compact reader, miDiagnostics can measure nearly any biomarker from a minimally invasive pattern akin to drops of fingerprick blood or swabs. The Firm is growing an intensive portfolio of exams for screening, prognosis and monitoring of a variety of well being situations, together with infectious ailments. Spun out of the world-leading R&D and innovation hub in nanoelectronics and digital applied sciences, imec, and a analysis collaboration with Johns Hopkins College, the main US analysis and medical centre, miDiagnostics’ aim is to allow quick, complete and cost-effective well being evaluation, no matter location.  Based mostly in Leuven, Belgium, miDiagnostics is a privately held firm created in 2015.


View unique content material to obtain multimedia:



The above press launch was offered courtesy of PRNewswire. The views, opinions and statements within the press launch are usually not endorsed by Grey Media Group nor do they essentially state or mirror these of Grey Media Group, Inc.

Source link

Odisha Expo

Odisha Expo

Odisha Expo is one of the Largest News Aggregator of Odisha, Stay Updated about the latest news with Odisha Expo from around the world. Stay hooked for more updates.

Related Posts

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.


Premium Content

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?